Abstract
The serendipitous discovery of covalent inhibitors and their characteristic potency of inducing irreversible and complete inhibition in therapeutic targets have caused a paradigm shift from the use of non-covalent drugs in disease treatment. This has caused a significant evolution in the field of covalent targeting to understand their inhibitory mechanisms and facilitate the systemic design of novel covalent modifiers for ‘undruggable’ targets. Computational techniques have evolved over the years and have significantly contributed to the process of drug discovery by mirroring the pattern of biological occurrences thereby providing insights into the dynamics and conformational transitions associated with biomolecular interactions. Moreover, our previous contributions towards the systematic design of selective covalent modifiers have revealed the various setbacks associated with the use of these conventional techniques in the study of covalent systems, hence there is a need for distinct approaches. In this review, we highlight the modifications and development of computational techniques suitable for covalent systems, their lapses, shortcomings and recent advancements.
Keywords: Covalent, Irreversible, Inhibition, Computational techniques, Molecular dynamics, Covalent docking, QM/MM.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Covalent Inhibition in Drug Discovery: Filling the Void in Literature
Volume: 18 Issue: 13
Author(s): Imane Bjij, Fisayo A. Olotu, Clement Agoni, Emmanuel Adeniji, Shama Khan, Ahmed El Rashedy, Driss Cherqaoui and Mahmoud E.S. Soliman*
Affiliation:
- Molecular Biocomputation and Drug Design Research Group, School of Health Sciences, University of KwaZulu-Natal, Westville, Durban 4000,south africa
Keywords: Covalent, Irreversible, Inhibition, Computational techniques, Molecular dynamics, Covalent docking, QM/MM.
Abstract: The serendipitous discovery of covalent inhibitors and their characteristic potency of inducing irreversible and complete inhibition in therapeutic targets have caused a paradigm shift from the use of non-covalent drugs in disease treatment. This has caused a significant evolution in the field of covalent targeting to understand their inhibitory mechanisms and facilitate the systemic design of novel covalent modifiers for ‘undruggable’ targets. Computational techniques have evolved over the years and have significantly contributed to the process of drug discovery by mirroring the pattern of biological occurrences thereby providing insights into the dynamics and conformational transitions associated with biomolecular interactions. Moreover, our previous contributions towards the systematic design of selective covalent modifiers have revealed the various setbacks associated with the use of these conventional techniques in the study of covalent systems, hence there is a need for distinct approaches. In this review, we highlight the modifications and development of computational techniques suitable for covalent systems, their lapses, shortcomings and recent advancements.
Export Options
About this article
Cite this article as:
Bjij Imane , Olotu A. Fisayo, Agoni Clement , Adeniji Emmanuel , Khan Shama , El Rashedy Ahmed , Cherqaoui Driss and Soliman E.S. Mahmoud *, Covalent Inhibition in Drug Discovery: Filling the Void in Literature, Current Topics in Medicinal Chemistry 2018; 18 (13) . https://dx.doi.org/10.2174/1568026618666180731161438
DOI https://dx.doi.org/10.2174/1568026618666180731161438 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements